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ABSTRACT 
A 24-year-old woman presented to the department of plastic surgery for surgical excision of a nevus on her nose. 
Although her history failed to reveal any cardiac disease, her pre-operative electrocardiogram (ECG) showed an ex-
tremely prolonged QT interval of up to 528 msec. Repeated history-taking after admission revealed three syncopal 
episodes associated with both physical and emotional stress, and because the two-dimensional echocardiography 
and exercise ECG test were normal except for the prolonged QT interval, an epinephrine test was done to assess 
QT interval changes after an epinephrine infusion. Immediately after a bolus injection of epinephrine (0.1 μg/kg), 
marked prolongation of the QT interval developed, followed by polymorphic ventricular tachycardia which was 
immediately terminated with direct current shock, resulting in the diagnosis of a long QT syndrome (LQTS), 
probably type 1. Gene studies were recommended, but declined by the patient and her family. She was instructed 
to avoid competitive sports, and a  β-blocker was prescribed after which she remained symptom-free. (Korean Circ J 
2009;39:386-388) 
 





Congenital long QT syndrome (LQTS) is a potentially 
lethal cardiac channelopathy that affects nearly 1 in 3,000 
people and has an estimated annual mortality of 1%.
1) 
LQTS may be occult for an indefinite time period or may 
present with syncope, seizures, or sudden death at a young 
age.
2) Our understanding of the genetic basis of LQTS is 
increasing,
3) giving us the ability to classify the disease into 
different types. For instance, one type of LQTS is trigger-
ed by exercise, especially swimming,
4) while another type of 
LQTS is associated with sleep or inactivity, and electrocar-
diographic abnormalities lessen with an increased heart 
rate. Yet another type of LQTS can be triggered by a startle 
response, e.g., something as seemingly benign as an alarm 
clock ringing. However, the diagnosis of LQTS still remains 
a challenge. The cardinal electrocardiogram (ECG) fea-
ture of LQTS, namely QT prolongation, can be difficult 
to recognize and may be non-specific. In addition, many 
physicians struggle with measuring or confirming the 
computer-derived rate-corrected QT interval (QTc).
5) He-
rein we report a case of epinephrine-induced polymor-
phic ventricular tachycardia in a patient with congenital 




A 24-year-old Korean woman presented to the depart-
ment of plastic surgery for surgical excision of a nevus on 
her nose. She was otherwise healthy and had no history 
of cardiac disease. Her routine pre-operative ECG showed 
a sinus rhythm with prolonged QT and QTc intervals 
as long as 528 and 562 ms, respectively (Fig. 1). Detailed 
history-taking after admission revealed three episodes 
of syncope associated with both physical and emotional 
upset, such as a 100 meter sprint, tug of war, and arguing 
with a stranger in a night club. Her family history was 
unremarkable for syncope or premature sudden death. 
Her routine laboratory findings and 2-dimentional echo-
cardiographic findings were also unremarkable. As her 
syncopal episodes were related to physical exertion, an 
exercise ECG was performed; however, the test was une-
ventful with no syncope or ventricular arrhythmia. Thus, 
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an epinephrine infusion test was performed according 
to the protocol of Shimizu and Antzelevitch.
6) Immedia-
tely after the bolus injection of 0.1  μg/kg of epineph-
rine, the ECG showed marked prolongation of the QT 
interval followed by polymorphic ventricular tachycardia 
(Fig. 2). Direct current shock promptly terminated the 
ventricular tachycardia and restored a sinus rhythm with 
prominent T wave alternans, which lasted for a few min-
utes. With all of these clinical features we made the di-
agnosis of a long QT syndrome, probably type 1. A gene 
study was recommended, which was declined by the pa-
tient and her family. She was recommended to avoid 
competitive sports, and atenolol (100 mg per day) was 
prescribed. She has remained symptom-free for more 




In this case, the patient’s resting ECG showed QT inter-
val prolongation and a broad-based T wave, while during 
the exercise stress test, no ventricular tachyarrhythmia was 
noted, and polymorphic ventricular tachycardia was induc-
ed only after epinephrine infusion. All of the patient’s fea-
tures were most consistent with a diagnosis of type 1 LQ-
TS.
7) If the patient had undergone an excision of the 
nevus under local anesthesia with local epinephrine to 
Fig. 1. Routine ECG showing sinus rhythm with markedly prolonged QT (528 ms) and QTc (562 ms) intervals. ECG: electrocardiogram.
Fig. 2. Development of polymorphic ventricular tachycardia after a bolus injection of epinephrine.  
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control bleeding with no pre-operative ECG, she might 
have suffered from cardiac arrest due to epinephrine-
induced polymorphic ventricular tachycardia. Even the 
patient considered the syncopal episodes as ‘simple fa-
ints’ with no clinical significance. A correct ECG reading 
and elaborate history-taking helped us determine the 
patient’s disease. This is the first case of epinephrine-
induced polymorphic ventricular tachycardia in Korea 
for the diagnosis of a suspected long QT syndrome. 
Recent lines of evidence have suggested that cardiac 
events associated with sympathetic stimulation are more 
common among the LQT1 than the LQT2 or LQT3 types 
of congenital LQTS.
4)8) Provocative testing, particularly the 
epinephrine QT stress test, may aid in unmasking such in-
dividuals with concealed LQTS, especially type 1 LQTS.
9)10) 
In the normal heart, epinephrine increases both ionotropy 
and chronotropy.
11) On the other hand, individuals with 
LQT1 have a compromised slow component of the delay-
ed rectifier potassium current (IKs) which is expected to 
shorten the QT intervals during tachycardia less effective-
ly than in normal individuals.
11) The superimposition of 
major catecholamine release, as happens during exercise 
without appropriate QT adaptation, sets the stage for early 
after-depolarizations, which may then lead to polymorphic 
ventricular tachycardia.
12) The critical role of an impaired 
IKs in the facilitation of adrenergic-dependent arrhyth-
mias has implications for therapy. Indeed, 88% of LQT1 
patients are at risk during conditions of sympathetic hyper-
activity, for example, exercise, head up tilt test,
13) or emo-
tions.
8) Thus, anti-adrenergic treatment is highly effective 
for LQT1.
14) β-adrenergic blockade does not shorten the 
QT interval at rest, but suppresses cardiac events in LQT1, 
whereas the efficacy of β-blockade is reduced in LQT2 
and unclear in LQT3.
14)  
The mortality of untreated and symptomatic patients 
with LQTS exceeds 20% in the year after the first syncopal 
episode and approaches 50% within 10 years;15 ) however, 
mortality can be significantly reduced by appropriate ther-
apy. A subsequent analysis that included only adults show-
ed a 60% reduction in the cardiac event rate with β -block-
ade.
16) Given the incomplete effectiveness of β -blockers in 
preventing sudden death in LQTS, implanting a cardio-
verter-defibrillator may be appropriate in some patients; 
however, the patient described herein has remained symp-
tom-free for more than 2 year with appropriate lifestyle 
modification and  β-blockers.  
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